close
close
migores1

Best and worst performing UK stocks since August 2024

The Morningstar UK Large-Mid Cap Index rose 0.9% in August on a boost in the healthcare sector. The Large-Mid Index tracks the performance of the top 90% of the UK investable universe by market capitalisation, and each month we sift through the stocks in the index to find the best and worst performers. The data in this article comes from Morningstar Direct.

• Entain (ENT)
• Next (NXT)
• GSK (GSK)
• Rolls-Royce Holdings (RR.)
• International Airlines Group (IAG)

Worst performing stocks since August 2024

• Melrose Industries (MRO)
• Ocado Group (OCDO)
• Spirax Group (SPX)
Burberry Group (BRBY)
• HUTCHMED (HCM)

Values ​​for the best performing stocks

Entain (ENT)

• Sector: Cyclical consumption
• Industry: Gambling
• Economic moat: not evaluated

Entain rose 14.8% in August, but is still down 42.7% over the past year. The stock is 45.7% below its latest high on September 4, 2023. The company’s stock has a Morningstar Quantitative Rating of 3 stars.

Next (NXT)

• Sector: Cyclical consumption
• Industry: Clothing retail
• Economic moat: not assessed

The latter rose 12.0% after rising 49.0% from a year ago. The company’s stock has a Morningstar Quantitative Rating of 2 stars.

GSK (GSK)

• Sector: Health
• Industry: Drug Manufacturers – General
• Economic ditch: Lat

GSK is up 10.6%, lifting shares 23.9% over the past year. The company’s shares have a Morningstar rating of 4 stars and trade at a 25% discount to its estimated value of £22.00.

Rolls-Royce Holdings (RR.)

• Sector: Industrial industry
• Industry: Aerospace and Defense
• Economic moat: Narrow

Rolls-Royce rose 10.4%, leaving the stock up 123.3% for the year. The company’s shares have a Morningstar rating of 2 stars and trade at a 31% premium to its estimated value of £3.80.

International Airlines Group (IAG)

• Sector: Industrial industry
• Industry: Airlines
• Economic moat: None

IAG is up 10.4%, pushing the stock up 13.0% over the past year. The company’s shares have a 4-star Morningstar rating and are trading at an 18% discount to their estimated value of £2.24.

Values ​​for the worst performing stocks

Melrose Industries (MRO)

• Sector: Industrial industry
• Industry: Specialized industrial equipment
• Economic ditch: Lat

Melrose Industries fell 17.8% in August and is down 4.8% over the past year. Shares are 29.3% below their latest high on April 8, 2024. The company’s shares have a 5-star Morningstar rating and are trading at a 35% discount to their estimated fair value of £7.40.

Ocado Group (OCDO)

• Sector: Consumer protection
• Industry: Grocery stores
• Economic moat: None

Ocado is down 15.9% and has fallen 60.9% over the past year. Shares are 62.2% below their last high on September 4, 2023. The company’s shares have a 5-star Morningstar rating and are trading at a 63% discount to its estimated value of £9.20.

Spirax Group (SPX)

• Sector: Industrial industry
• Industry: Specialized industrial equipment
• Economic ditch: Lat

Spirax is down 15.1% and is down 22.7% over the past year. Shares are 31.8% below their latest high on March 7, 2024. The company’s stock has a 4-star Morningstar rating and is trading at a 20% discount to its estimated value of £96.50.

Burberry Group (BRBY)

• Sector: Cyclical consumption
• Industry: Luxury goods
• Economic moat: Narrow

Burberry fell 13.8%, down 67.6% from a year ago. Shares are 70.0% below their latest high on September 4, 2023. The company’s shares have a 5-star Morningstar rating and trade at a 50% discount to its estimated value of £13.30.

HUTCHMED (HCM)

• Sector: Health
• Industry: Drug Manufacturers – Specialty and Generic
• Economic moat: not evaluated

Hutchmed fell 12.7%, but shares were still up 10.1% for the year. The stock is 25.8% below its latest high on May 10, 2024. The company’s stock has a Morningstar Quantitative Rating of 4 stars.

Companies not formally covered by a Morningstar analyst are statistically correlated with analyst-rated companies, allowing our models to calculate a quantitative star rating.

This article has been generated with the help of automation and reviewed by Morningstar editors.

Related Articles

Back to top button